Australia markets open in 3 hours 35 minutes

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
27.77+0.75 (+2.78%)
At close: 03:00PM CST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
799,093
784,347
829,072
767,137
636,051
Cost of revenue
139,321
135,528
129,207
126,373
105,672
Gross profit
659,771
648,819
699,864
640,765
530,379
Operating expenses
Research development
49,679
49,683
47,824
50,825
48,485
Selling general and administrative
363,876
360,726
356,565
355,429
309,012
Total operating expenses
423,996
422,389
432,505
440,809
374,181
Operating income or loss
235,775
226,431
267,359
199,956
156,198
Interest expense
19,955
24,703
13,028
10,170
11,716
Income before tax
269,089
254,911
277,966
201,061
153,702
Income tax expense
89.4498
430.8731
452.5683
749.2865
1,990
Income from continuing operations
269,000
254,480
277,513
200,311
151,712
Net income
269,000
254,480
277,783
200,827
151,712
Net income available to common shareholders
269,000
254,480
277,783
200,827
151,712
Basic EPS
1.47
1.30
1.43
1.05
0.82
Diluted EPS
1.47
1.30
1.43
1.05
0.82
Basic average shares
195,791
195,754
194,254
191,263
184,323
Diluted average shares
195,791
195,754
194,254
191,263
184,323